Cadila Healthcare has acquired all shares held by its subsidiary companies in Zydus Pharmaceuticals USA Inc., USA, Zydus Healthcare USA LLC, Zydus Noveltech USA, Inc. and Bremer Pharma GmbH, Germany and therefore these four entities have become direct overseas subsidiary companies.
Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.
